Instil Bio, Inc.
TIL· Nasdaq
Released Nov 13, 2023, after the close
10-Q filed Nov 13, 2023, 44 days after period end · 0001789769-23-000091
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $52.00K |
| Net Income | -$67.43M | -$56.22M | -$43.01M | -$7.26M |
| EPS Diluted |
Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR
| -$10.37 |
| -$0.43 |
| -$0.33 |
| -$0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.